Focus research 2022 SigDyn team
Cross-regulation between PI3Ks
Can they be used to better prevent tumor progression?
PI3Ks are a family of three classes of enzymes essential to cell life and which are frequently deregulated in cancer. The dependence of tumors on different types of class I PI3Ks is governed by putative genetic mutations and the tumor context (inflammation, etc.). While knowledge of class II and III PI3Ks in cancer is still too limited, class I PI3Ks seem to be dependent on mechanisms similar to those responsible for tumoral growth. The future of anti-cancer therapies targeting PI3Ks lies in a better understanding of these enzymes and the simultaneous targeting of several classes of PI3Ks with innovative drugs.
This project, coordinated by Dr Benoit Thibault and Dr Julie Guillermet-Guibert, will benefit in 2022 from the permanent recruitment of Dr Benoit Thibault as an Inserm researcher.
To find out more about the IUCT-Oncopole and CRCT-Oncopole research focuses, please click here
Centre de Recherches contre le Cancer de Toulouse (Oncopole)
Toulouse - FR
CRCT-Oncopole Follow 1,220 1,117
Compte officiel du Centre de Recherches en Cancérologie de Toulouse
;
Castelnau-Montratier célèbre la lutte contre le cancer. Jeudi 24 août 2023 conférence avec Frédéric Chibon responsable de l'équipe @OncoSarc du @crctoncopole accompagné de Gwenaël Ferron et Martin Gauthier oncologue @IUCTOncopole
Découvrir l'équipe
➡️https://www.crct-inserm.fr/oncosarc/
Nous contacter
+33 5 82 74 15 75
Nous rejoindre ?
